Novo Nordisk’s Stock Rises As Weight Loss Drug Sales Accelerate
Shares of Novo Nordisk (NVO) are up 8% in European trading after the Danish pharmaceutical company posted financial results that showed accelerating sales of its weight loss medications. The drug maker’s third-quarter sales came in slightly below
Danish drugmaker Novo Nordisk's shares hit an over 9-month low on Thursday after surging more than 8% the previous day, as ...
Novo Nordisk (NVO) has released an update. Novo Nordisk announced that its board members and executives have sold a significant volume of ...
Key Takeaways Danish pharmaceutical giant Novo Nordisk is set to report earnings for the third quarter of 2024 on Wednesday ...
4don MSN
Telehealth company Hims & Hers said late Monday in an earnings update that it plans to launch a generic version of Novo ...
Novo Nordisk (NVO) has released an update. Novo Nordisk, a leading global healthcare company, recently reported that its board members and ...
Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including ...
CBS News on MSN6d
Novo Nordisk's obesity-fighting drugs are fattening Denmark's economy while shrinking other sectorsMadsen, who has stock in the company, is particularly proud that Novo Nordisk is now bigger than any firms their ...
Novo Nordisk's valuation remains high, trading at a significant historical premium. Click here to see why NVO stock is a Sell ...
Bloomberg L.P. on MSN12d
Novo Nordisk Shares Seen Outpacing Lilly’s After Summer StumbleNovo Nordisk A/S has fallen behind Eli Lilly & Co. this year in the race to be the big stock market winner from obesity ...
The Motley Fool on MSN2d
Got $5,000? Viking Therapeutics Stock Just Got a Big New Green FlagThe company's latest presentation supports the idea that its lead program will make billions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback